Dose determinants in continuous renal replacement therapy

Artificial Organs

Volumn 27, Issue 9, 2003, Pages 815-820

  Clark, William R ^a,b,d   Turk, Joseph E ^a   Kraus, Michael A ^b   Gao, Dayong ^c  

^a NxStage Medical Inc ^*  (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

^d WISHARD MEMORIAL HOSPITAL   (United States)

Author keywords

Continuous renal replacement therapy; Dose; Hemodialysis; Hemofiltration

Indexed keywords

HEMODIALYZERS; PATIENT TREATMENT;

BLOOD-FLOW RATES; CONTINUOUS RENAL REPLACEMENT THERAPY; CRITICALLY-ILL PATIENTS; DOSE; DOSE DELIVERY; DOSE PRESCRIPTION; HAEMODIALYSIS; HEMOFILTRATION; RENAL FAILURE; RENAL REPLACEMENT THERAPIES;

DIALYSIS;

ACUTE KIDNEY FAILURE; BLOOD FLOW VELOCITY; DOSE CALCULATION; HEMODIALYSIS; HEMODILUTION; HEMOFILTRATION; HUMAN; PRIORITY JOURNAL; REVIEW; SURVIVAL; TREATMENT OUTCOME;

EID: 0043236330     PISSN: 0160564X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1594.2003.07288.x     Document Type: Review

References (26)

1. Clark WR, Murphy MH, Alaka KJ, Mueller BA, Pastan SO, Macias WL. Urea kinetics in continuous hemofiltration. ASAIO J 1992;38:664-7.
2. Clark WR, Mueller BA, Alaka KJ, Macias WL. A comparison of metabolic control by continuous and intermittent therapies in acute renal failure. J Am Soc Nephrol 1994;4:1413-20.
3. Paganini EP, Tapolyai M, Goormastic M, et al. Establishing a dialysis therapy/patient outcome link in intensive care unit acute dialysis for patients with acute renal failure. Am J Kidney Dis 1996;28(suppl 3):S81-9.
4. Clark WR, Mueller BA, Kraus MA, Macias WL. Extracorporeal therapy requirements for patients with acute renal failure. J Am Soc Nephrol 1997;8:804-12.
5. Evanson JA, Himmelfarb J, Wingard R, et al. Prescribed versus delivered dialysis in acute renal failure patients. Am J Kidney Dis 1998;32:731-8.
6. Evanson J, Ikizler T, Wingard R, et al. Measurement of the delivery of dialysis dose in acute renal failure. Kidney Int 1999;55:1501-8.
7. Ronco C, Bellomo R, Hommel P, et al. Effects of different doses in continuous veno-venous hemofiltration on outcomes in acute renal failure: a prospective, randomized trial. Lancet 2000;355:26-30.
8. Schiffl H, Lang SM, Fischer R. Daily hemodialysis and the outcome of acute renal failure. N Engl J Med 2002;346:305-10.
9. Gillum DM, Dixon BS, Yanover MJ, et al. The role of intensive dialysis in acute renal failure. Clin Nephrol 1986;25:249-55.
10. Daugirdas JT. Second-generation estimates of single-pool variable volume Kt/V: an analysis of error. J Am Soc Nephrol 1993;4:1205-13.
11. Clark WR, Leypoldt JK, Henderson LW, Mueller BA, Scott MK, Vonesh EF. Quantifying the effect of changes in the hemodialysis prescription on effective solute removal with a mathematical model. J Am Soc Nephrol 1999;10:601-9.
12. Casino FG, Lopez T. The equivalent renal urea clearance: a new parameter to assess dialysis dose. Nephrol Dial Transplant 1996;11:1574-91.
13. Clark WR, Henderson LW. Renal vs. continuous vs. intermittent therapies for removal of uremic toxins. Kidney Int 2001;59(suppl 78):S298-303.
14. Gotch FA. The current place of urea kinetic modeling with respect to different dialysis modalities. Nephrol Dial Transplant 1998;13(suppl 6):10-4.
15. Storck M, Hartl W, Zimmerer E, Inthorn D. Comparison of pump-driven and spontaneous hemofiltration in postoperative acute renal failure. Lancet 1991;337:452-5.
16. Clark WR, Ronco C. Renal replacement therapy quantification in acute renal failure: solute removal mechanisms and dose quantification. Kidney Int 1998;53(suppl 66):S133-7.
17. Honore PM, Jamez J, Wauthier M, et al. Prospective evaluation of short-term, high-volume isovolemic hemofiltration on the hemodynamic course and outcome in patients with intractable circulatory failure resulting from septic shock. Crit Care Med 2000;28:3581-7.
18. Gettings LG, Reynolds HN, Scalea T. Outcome in post-traumatic acute renal failure when continuous renal replacement therapy is applied early vs. late. Intensive Care Med 1999;25:805-13.
19. Clark WR, Rocco MV, Collins AJ. Quantification of hemodialysis: analysis of methods and relevance to clinical outcome. Blood Purif 1997;15:92-111.
20. NKF-K/DOQI Clinical Practice Guidelines for Hemodialysis Adequacy: Update 2000. Am J Kidney Dis 2001;37(suppl 1):S7-64.
21. Clark WR, Gao D. Low-molecular weight proteins in end-stage renal disease: potential toxicity and dialytic removal mechanisms. J Am Soc Nephrol 2002;13:S41-7.
22. Brunet S, Leblanc M, Geadah D, Parent D, Corteau S, Cardinal J. Diffusive and convective solute clearance during continuous renal replacement therapy at various dialysate and ultrafiltration flow rates. Am J Kidney Dis 1999;34:486-92.
23. Shinaberger J, Miller J, Gardner P. Erythropoietin alert: risks of high hematocrit hemodialysis. Trans Am Soc Artif Intern Organs 1988;34:179-84.
24. Holt AW, Bierer P, Bersten AD, Bury LK, Vedig AE. Continuous renal replacement therapy in critically ill patients: monitoring circuit function. Anaesth Intens Care 1996;24:423-9.
25. Troyanov S, Cardinal J, Geadah D, et al. Solute clearances during continuous venovenous haemofiltration at various ultrafiltration flow rates using Multiflow-100 and HF1000 filters. Nephrol Dial Transplant 2003;18:961-6.
26. Venkataraman R, Kellum JA, Palevsky P. Dosing patterns for continuous renal replacement therapy at a large academic medical center in the United States. J Crit Care 2002;17:246-50.